- Home
- EXPI vs ORIC Comparison
EXPI vs ORIC Comparison
Compare EXPI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXPI | ORIC |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 861.3M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EXPI | ORIC |
|---|---|---|
| Price | $6.76 | $8.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $9.75 | ★ $19.73 |
| AVG Volume (30 Days) | 1.0M | ★ 1.0M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $500,147,681.00 | N/A |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $5.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 220.39 | N/A |
| 52 Week Low | $5.66 | $7.23 |
| 52 Week High | $12.23 | $14.93 |
Technical Indicators
Market Signals| Indicator | EXPI | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 39.95 |
| Support Level | $5.68 | $7.83 |
| Resistance Level | $6.87 | $11.22 |
| Average True Range (ATR) | 0.23 | 0.43 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 81.56 | 48.22 |
Price Performance
Historical ComparisonAbout EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.